A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema

PHASE3CompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

December 16, 2024

Study Completion Date

September 12, 2025

Conditions
Chronic Hand Eczema
Interventions
DRUG

Delgocitinib

Topical administration

OTHER

Vehicle cream

Topical administration

Trial Locations (37)

100044

LEO Pharma Investigational Site, Beijing

100050

LEO Pharma Investigational Site, Beijing

100080

LEO Pharma Investigational Site, Beijing

100730

LEO Pharma Investigational Site, Beijing

110002

LEO Pharma Investigational Site, Shenyang

130021

LEO Pharma Investigational Site, Changchun

200443

LEO Pharma Investigational Site, Shanghai

210003

LEO Pharma Investigational Site, Nanjing

212000

LEO Pharma Investigational Site, Zhenjiang

213000

LEO Pharma Investigational Site, Changzhou

214043

LEO Pharma Investigational Site, Wuxi

230601

LEO Pharma Investigational Site, Hefei

310003

LEO Pharma Investigational Site, Hangzhou

310006

LEO Pharma Investigational Site, Hangzhou

310014

LEO Pharma Investigational Site, Hangzhou

322000

LEO Pharma Investigational Site, Yiwu

325000

LEO Pharma Investigational Site, Wenzhou

330200

LEO Pharma Investigational Site, Nanchang

350005

LEO Pharma Investigational Site, Fuzhou

410008

LEO Pharma Investigational Site, Changsha

410011

LEO Pharma Investigational Site, Changsha

430023

LEO Pharma Investigational Site, Wuhan

430030

LEO Pharma Investigational Site, Wuhan

430071

LEO Pharma Investigational Site, Wuhan

473112

LEO Pharma Investigational Site, Nanyang

510030

LEO Pharma Investigational Site, Guangzhou

510260

LEO Pharma Investigational Site, Guangzhou

518020

LEO Pharma Investigational Site, Shenzhen

518033

LEO Pharma Investigational Site, Shenzhen

518052

LEO Pharma Investigational Site, Shenzhen

518058

LEO Pharma Investigational Site, Shenzhen

550004

LEO Pharma Investigational Site, Guiyang

610021

LEO Pharma Investigational Site, Chengdu

610044

LEO Pharma Investigational Site, Chengdu

712000

LEO Pharma Investigational Site, Xianyang

750003

LEO Pharma Investigational Site, Yinchuan

050030

LEO Pharma Investigational Site, Shijiazhuang

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY